Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

NGF-Enhanced Vasculogenic Properties of Epithelial Ovarian Cancer Cells Is Reduced by Inhibition of the COX-2/PGE2 Signaling Axis.

Garrido MP, Hurtado I, Valenzuela-Valderrama M, Salvatierra R, Hernández A, Vega M, Selman A, Quest AFG, Romero C.

Cancers (Basel). 2019 Dec 7;11(12). pii: E1970. doi: 10.3390/cancers11121970.

2.

Paraneoplastic cerebellar degeneration in a patient with a primary fallopian tube adenocarcinoma. A case report and brief review.

Campero M, Selman AE.

Gynecol Oncol Rep. 2017 Mar 27;20:90-92. doi: 10.1016/j.gore.2017.03.019. eCollection 2017 May.

3.

The nerve growth factor alters calreticulin translocation from the endoplasmic reticulum to the cell surface and its signaling pathway in epithelial ovarian cancer cells.

Vera CA, Oróstica L, Gabler F, Ferreira A, Selman A, Vega M, Romero CA.

Int J Oncol. 2017 Apr;50(4):1261-1270. doi: 10.3892/ijo.2017.3892. Epub 2017 Feb 28.

PMID:
28260038
4.

Effect of estradiol on the expression of angiogenic factors in epithelial ovarian cancer.

Valladares M, Plaza-Parrochia F, Lépez M, López D, Gabler F, Gayan P, Selman A, Vega M, Romero C.

Histol Histopathol. 2017 Nov;32(11):1187-1196. doi: 10.14670/HH-11-874. Epub 2017 Jan 24.

PMID:
28116735
5.

Author's reply re: Caesarean hysterectomy for placenta praevia/accreta using an approach via the pouch of Douglas.

Selman AE.

BJOG. 2016 Sep;123(10):1712-3. doi: 10.1111/1471-0528.13972. No abstract available.

6.

Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells.

Kohan-Ivani K, Gabler F, Selman A, Vega M, Romero C.

J Cancer Res Clin Oncol. 2016 Jan;142(1):47-58. doi: 10.1007/s00432-015-1998-y. Epub 2015 Jun 20.

7.

Tyrosine kinase A receptor (trkA): a potential marker in epithelial ovarian cancer.

Tapia V, Gabler F, Muñoz M, Yazigi R, Paredes A, Selman A, Vega M, Romero C.

Gynecol Oncol. 2011 Apr;121(1):13-23. doi: 10.1016/j.ygyno.2010.12.341. Epub 2011 Jan 14.

PMID:
21236475
8.

Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer.

Campos X, Muñoz Y, Selman A, Yazigi R, Moyano L, Weinstein-Oppenheimer C, Lara HE, Romero C.

Gynecol Oncol. 2007 Jan;104(1):168-75. Epub 2006 Aug 28.

PMID:
16935322
9.

Surgical management of recurrent cervical cancer.

Selman AE, Copeland LJ.

Yonsei Med J. 2002 Dec;43(6):754-62. Review.

10.

Secondary cytoreductive surgery in the patient with recurrent ovarian cancer is often beneficial.

Selman AE, Copeland LJ.

Crit Rev Oncol Hematol. 2002 Mar;41(3):335-41. Review.

PMID:
11880209

Supplemental Content

Loading ...
Support Center